Click here to get full coverage on uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences - Yahoo Finance

uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences  Yahoo Finance

uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences - Yahoo Finance

Click here to get full coverage on A Deep Dive into uniQure (QURE) Valuation After FDA Uncertainty Shakes Huntington’s Disease Program - simplywall.st

A Deep Dive into uniQure (QURE) Valuation After FDA Uncertainty Shakes Huntington’s Disease Program  simplywall.st

A Deep Dive into uniQure (QURE) Valuation After FDA Uncertainty Shakes Huntington’s Disease Program - simplywall.st

Click here to get full coverage on New Analyst Forecast: $QURE Given $60.0 Price Target - Quiver Quantitative

New Analyst Forecast: $QURE Given $60.0 Price Target  Quiver Quantitative

New Analyst Forecast: $QURE Given $60.0 Price Target - Quiver Quantitative

Click here to get full coverage on NASDAQ: QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire

NASDAQ: QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm  NewMediaWire

NASDAQ: QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire

Click here to get full coverage on uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences - Insider Monkey

uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences  Insider Monkey

uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences - Insider Monkey

Click here to get full coverage on uniQure (QURE): Wells Fargo Adjusts Price Target to $60, Maintai - GuruFocus

uniQure (QURE): Wells Fargo Adjusts Price Target to $60, Maintai  GuruFocus

uniQure (QURE): Wells Fargo Adjusts Price Target to $60, Maintai - GuruFocus

Click here to get full coverage on From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside (NASDAQ:QURE) - Seeking Alpha

From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside (NASDAQ:QURE)  Seeking Alpha

From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside (NASDAQ:QURE) - Seeking Alpha

Click here to get full coverage on uniQure (QURE) Q3 2025 Earnings Call Transcript - The Motley Fool

uniQure (QURE) Q3 2025 Earnings Call Transcript  The Motley Fool

uniQure (QURE) Q3 2025 Earnings Call Transcript - The Motley Fool

Click here to get full coverage on Chardan Capital Maintains uniQure N.V. (QURE) Buy Recommendation - Nasdaq

Chardan Capital Maintains uniQure N.V. (QURE) Buy Recommendation  Nasdaq

Chardan Capital Maintains uniQure N.V. (QURE) Buy Recommendation - Nasdaq

Click here to get full coverage on What’s next for QURE stock price - Market Activity Recap & Long-Term Growth Portfolio Plans - newser.com

What’s next for QURE stock price - Market Activity Recap & Long-Term Growth Portfolio Plans  newser.com

What’s next for QURE stock price - Market Activity Recap & Long-Term Growth Portfolio Plans - newser.com

Click here to get full coverage on UniQure Stock (QURE) Plummets 67% on FDA News. Here’s Why. - Barron's

UniQure Stock (QURE) Plummets 67% on FDA News. Here’s Why.  Barron's

UniQure Stock (QURE) Plummets 67% on FDA News. Here’s Why. - Barron's

Click here to get full coverage on uniQure NV (QURE) Q3 2025 Earnings Call Highlights: Promising Data Amid Regulatory Challenges - Yahoo Finance

uniQure NV (QURE) Q3 2025 Earnings Call Highlights: Promising Data Amid Regulatory Challenges  Yahoo Finance

uniQure NV (QURE) Q3 2025 Earnings Call Highlights: Promising Data Amid Regulatory Challenges - Yahoo Finance

Click here to get full coverage on $QURE stock is up 15% today. Here's what we see in our data. - Quiver Quantitative

$QURE stock is up 15% today. Here's what we see in our data.  Quiver Quantitative

$QURE stock is up 15% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates  Yahoo Finance

uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm - PR Newswire

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm  PR Newswire

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm - PR Newswire

Click here to get full coverage on uniQure (QURE) Is Down 14.1% After FDA Alters AMT-130 Approval Pathway - Has The Bull Case Changed? - simplywall.st

uniQure (QURE) Is Down 14.1% After FDA Alters AMT-130 Approval Pathway - Has The Bull Case Changed?  simplywall.st

uniQure (QURE) Is Down 14.1% After FDA Alters AMT-130 Approval Pathway - Has The Bull Case Changed? - simplywall.st

Click here to get full coverage on uniQure (NASDAQ: QURE) highlights AMT-130 75% slowing at 36 months; FDA follow-up set - Stock Titan

uniQure (NASDAQ: QURE) highlights AMT-130 75% slowing at 36 months; FDA follow-up set  Stock Titan

uniQure (NASDAQ: QURE) highlights AMT-130 75% slowing at 36 months; FDA follow-up set - Stock Titan

Click here to get full coverage on Liquidity Mapping Around (QURE) Price Events - news.stocktradersdaily.com

Liquidity Mapping Around (QURE) Price Events  news.stocktradersdaily.com

Liquidity Mapping Around (QURE) Price Events - news.stocktradersdaily.com

Click here to get full coverage on Chardan Capital Maintains 'Buy' Rating on QURE with $53 Price Ta - GuruFocus

Chardan Capital Maintains 'Buy' Rating on QURE with $53 Price Ta  GuruFocus

Chardan Capital Maintains 'Buy' Rating on QURE with $53 Price Ta - GuruFocus

Click here to get full coverage on uniQure (QURE) Q3 Earnings Miss Expectations, Revenue Up 61.6% Y - GuruFocus

uniQure (QURE) Q3 Earnings Miss Expectations, Revenue Up 61.6% Y  GuruFocus

uniQure (QURE) Q3 Earnings Miss Expectations, Revenue Up 61.6% Y - GuruFocus

Click here to get full coverage on QURE: Leerink Partners Lowers Price Target, Maintains Outperform Rating | QURE Stock News - GuruFocus

QURE: Leerink Partners Lowers Price Target, Maintains Outperform Rating | QURE Stock News  GuruFocus

QURE: Leerink Partners Lowers Price Target, Maintains Outperform Rating | QURE Stock News - GuruFocus

Click here to get full coverage on Decoding uniQure NV (QURE): A Strategic SWOT Insight - GuruFocus

Decoding uniQure NV (QURE): A Strategic SWOT Insight  GuruFocus

Decoding uniQure NV (QURE): A Strategic SWOT Insight - GuruFocus

Click here to get full coverage on Is QURE meeting your algorithmic filter criteria - Gap Down & Free AI Powered Buy and Sell Recommendations - newser.com

Is QURE meeting your algorithmic filter criteria - Gap Down & Free AI Powered Buy and Sell Recommendations  newser.com

Is QURE meeting your algorithmic filter criteria - Gap Down & Free AI Powered Buy and Sell Recommendations - newser.com

Click here to get full coverage on uniQure (NASDAQ: QURE) updates on AMT-130; FDA feedback shifts, BLA timing unclear - Stock Titan

uniQure (NASDAQ: QURE) updates on AMT-130; FDA feedback shifts, BLA timing unclear  Stock Titan

uniQure (NASDAQ: QURE) updates on AMT-130; FDA feedback shifts, BLA timing unclear - Stock Titan

Click here to get full coverage on uniQure (QURE) Reveals Promising Data Amid Regulatory Challenges - GuruFocus

uniQure (QURE) Reveals Promising Data Amid Regulatory Challenges  GuruFocus

uniQure (QURE) Reveals Promising Data Amid Regulatory Challenges - GuruFocus

Click here to get full coverage on uniQure (QURE) Faces Uncertainty in BLA Submission Despite Positive AMT-130 Data - GuruFocus

uniQure (QURE) Faces Uncertainty in BLA Submission Despite Positive AMT-130 Data  GuruFocus

uniQure (QURE) Faces Uncertainty in BLA Submission Despite Positive AMT-130 Data - GuruFocus

Click here to get full coverage on uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results - Yahoo Finance

uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results  Yahoo Finance

uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results - Yahoo Finance

Click here to get full coverage on uniQure (QURE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance

uniQure (QURE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release  Yahoo Finance

uniQure (QURE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance

Click here to get full coverage on Will QURE rebound enough to break even - Portfolio Growth Summary & Advanced Swing Trade Entry Alerts - newser.com

Will QURE rebound enough to break even - Portfolio Growth Summary & Advanced Swing Trade Entry Alerts  newser.com

Will QURE rebound enough to break even - Portfolio Growth Summary & Advanced Swing Trade Entry Alerts - newser.com

Click here to get full coverage on H.C. Wainwright Raises the PT on uniQure N.V. (QURE), Keeps a Buy Rating - Yahoo Finance

H.C. Wainwright Raises the PT on uniQure N.V. (QURE), Keeps a Buy Rating  Yahoo Finance

H.C. Wainwright Raises the PT on uniQure N.V. (QURE), Keeps a Buy Rating - Yahoo Finance

Click here to get full coverage on QURE Investor ALERT: Block & Leviton Investigating uniQure - GlobeNewswire

QURE Investor ALERT: Block & Leviton Investigating uniQure  GlobeNewswire

QURE Investor ALERT: Block & Leviton Investigating uniQure - GlobeNewswire

Click here to get full coverage on uniQure Q3 2025 Earnings Call Transcript - MarketBeat

uniQure Q3 2025 Earnings Call Transcript  MarketBeat

uniQure Q3 2025 Earnings Call Transcript - MarketBeat

Click here to get full coverage on A Beauty Editor Compares the Qure vs. Omnilux Red Light Therapy Mask - PureWow

A Beauty Editor Compares the Qure vs. Omnilux Red Light Therapy Mask  PureWow

A Beauty Editor Compares the Qure vs. Omnilux Red Light Therapy Mask - PureWow

Click here to get full coverage on Qure.ai nets new U.S. FDA clearance for AI software - AuntMinnie

Qure.ai nets new U.S. FDA clearance for AI software  AuntMinnie

Qure.ai nets new U.S. FDA clearance for AI software - AuntMinnie

Click here to get full coverage on HC Wainwright & Co. Maintains uniQure N.V. (QURE) Buy Recommendation - Nasdaq

HC Wainwright & Co. Maintains uniQure N.V. (QURE) Buy Recommendation  Nasdaq

HC Wainwright & Co. Maintains uniQure N.V. (QURE) Buy Recommendation - Nasdaq

Click here to get full coverage on Will QURE stock outperform Dow Jones index - 2025 Performance Recap & AI Powered Buy and Sell Recommendations - newser.com

Will QURE stock outperform Dow Jones index - 2025 Performance Recap & AI Powered Buy and Sell Recommendations  newser.com

Will QURE stock outperform Dow Jones index - 2025 Performance Recap & AI Powered Buy and Sell Recommendations - newser.com

Click here to get full coverage on $QURE stock is down 66% today. Here's what we see in our data. - Quiver Quantitative

$QURE stock is down 66% today. Here's what we see in our data.  Quiver Quantitative

$QURE stock is down 66% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Earnings Flash (QURE) uniQure N.V. Reports Q3 Revenue $3.7M, vs. FactSet Est of $5.8M - MarketScreener

Earnings Flash (QURE) uniQure N.V. Reports Q3 Revenue $3.7M, vs. FactSet Est of $5.8M  MarketScreener

Earnings Flash (QURE) uniQure N.V. Reports Q3 Revenue $3.7M, vs. FactSet Est of $5.8M - MarketScreener

Click here to get full coverage on Why uniQure (QURE) Is Up After Positive AMT-130 Trial Results and Major New Funding Announcements - Yahoo Finance

Why uniQure (QURE) Is Up After Positive AMT-130 Trial Results and Major New Funding Announcements  Yahoo Finance

Why uniQure (QURE) Is Up After Positive AMT-130 Trial Results and Major New Funding Announcements - Yahoo Finance

Click here to get full coverage on NASDAQ: QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - Business Wire

NASDAQ: QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm  Business Wire

NASDAQ: QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - Business Wire

Click here to get full coverage on uniQure (NASDAQ: QURE) to Host Earnings Call Nov. 10 at 8:30 a.m. ET, before market open - Stock Titan

uniQure (NASDAQ: QURE) to Host Earnings Call Nov. 10 at 8:30 a.m. ET, before market open  Stock Titan

uniQure (NASDAQ: QURE) to Host Earnings Call Nov. 10 at 8:30 a.m. ET, before market open - Stock Titan

Click here to get full coverage on UniQure: Controversy Abounds As Stock Price Halves On FDA News (NASDAQ:QURE) - Seeking Alpha

UniQure: Controversy Abounds As Stock Price Halves On FDA News (NASDAQ:QURE)  Seeking Alpha

UniQure: Controversy Abounds As Stock Price Halves On FDA News (NASDAQ:QURE) - Seeking Alpha

Click here to get full coverage on New Analyst Forecast: $QURE Given $53.0 Price Target - Quiver Quantitative

New Analyst Forecast: $QURE Given $53.0 Price Target  Quiver Quantitative

New Analyst Forecast: $QURE Given $53.0 Price Target - Quiver Quantitative

Click here to get full coverage on uniQure N.V. (QURE) Reports Positive Phase I/II Results, Prepares FDA BLA Submission - Yahoo Finance

uniQure N.V. (QURE) Reports Positive Phase I/II Results, Prepares FDA BLA Submission  Yahoo Finance

uniQure N.V. (QURE) Reports Positive Phase I/II Results, Prepares FDA BLA Submission - Yahoo Finance

Click here to get full coverage on uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results - MSN

uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results  MSN

uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results - MSN

Click here to get full coverage on Earnings Flash (QURE) UniQure Posts Q3 Net Loss $1.38 a Share, vs. FactSet Est of $0.90 Loss - MarketScreener

Earnings Flash (QURE) UniQure Posts Q3 Net Loss $1.38 a Share, vs. FactSet Est of $0.90 Loss  MarketScreener

Earnings Flash (QURE) UniQure Posts Q3 Net Loss $1.38 a Share, vs. FactSet Est of $0.90 Loss - MarketScreener

Click here to get full coverage on INVESTOR ALERT: Investigation of uniQure N.V. (QURE) Announced by Holzer & Holzer, LLC - GlobeNewswire

INVESTOR ALERT: Investigation of uniQure N.V. (QURE) Announced by Holzer & Holzer, LLC  GlobeNewswire

INVESTOR ALERT: Investigation of uniQure N.V. (QURE) Announced by Holzer & Holzer, LLC - GlobeNewswire

Click here to get full coverage on uniQure N.V. (QURE) Stock: Plunges 57% After Unexpected FDA Setback on AMT-130 - CoinCentral

uniQure N.V. (QURE) Stock: Plunges 57% After Unexpected FDA Setback on AMT-130  CoinCentral

uniQure N.V. (QURE) Stock: Plunges 57% After Unexpected FDA Setback on AMT-130 - CoinCentral

Click here to get full coverage on Bronstein, Gewirtz & Grossman, LLC Encourages uniQure N.V. (QURE) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Encourages uniQure N.V. (QURE) Stockholders to Inquire about Securities Investigation  ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Encourages uniQure N.V. (QURE) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Click here to get full coverage on NASDAQ: QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - Markets Financial Content

NASDAQ: QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm  Markets Financial Content

NASDAQ: QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - Markets Financial Content

Click here to get full coverage on QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study - Yahoo Finance

QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study  Yahoo Finance

QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study - Yahoo Finance

Click here to get full coverage on Breakout Momentum Plays You Need to Know About - MarketBeat

Breakout Momentum Plays You Need to Know About  MarketBeat

Breakout Momentum Plays You Need to Know About - MarketBeat

Click here to get full coverage on TIME100 Most Influential Companies 2025: Qure.ai - Time Magazine

TIME100 Most Influential Companies 2025: Qure.ai  Time Magazine

TIME100 Most Influential Companies 2025: Qure.ai - Time Magazine

Click here to get full coverage on Volatility clustering patterns for QURE - Earnings Risk Report & Consistent Return Strategy Ideas - newser.com

Volatility clustering patterns for QURE - Earnings Risk Report & Consistent Return Strategy Ideas  newser.com

Volatility clustering patterns for QURE - Earnings Risk Report & Consistent Return Strategy Ideas - newser.com

Click here to get full coverage on How FDA’s Revised Stance on AMT-130 Data Has Changed uniQure’s (QURE) Investment Story - simplywall.st

How FDA’s Revised Stance on AMT-130 Data Has Changed uniQure’s (QURE) Investment Story  simplywall.st

How FDA’s Revised Stance on AMT-130 Data Has Changed uniQure’s (QURE) Investment Story - simplywall.st

Click here to get full coverage on uniQure (QURE): Examining Valuation Following Recent Share Price Volatility - simplywall.st

uniQure (QURE): Examining Valuation Following Recent Share Price Volatility  simplywall.st

uniQure (QURE): Examining Valuation Following Recent Share Price Volatility - simplywall.st

Click here to get full coverage on QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm - GlobeNewswire

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm  GlobeNewswire

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm - GlobeNewswire

Click here to get full coverage on Why Is UniQure Stock (QURE) Down 60% Today? - TipRanks

Why Is UniQure Stock (QURE) Down 60% Today?  TipRanks

Why Is UniQure Stock (QURE) Down 60% Today? - TipRanks

Click here to get full coverage on Strength Seen in uniQure (QURE): Can Its 247.7% Jump Turn into More Strength? - Nasdaq

Strength Seen in uniQure (QURE): Can Its 247.7% Jump Turn into More Strength?  Nasdaq

Strength Seen in uniQure (QURE): Can Its 247.7% Jump Turn into More Strength? - Nasdaq

Click here to get full coverage on I'm A Beauty Editor—My Favorite LED Face Mask Is 30% Off Before Prime Day Ends Tonight - Women's Health

I'm A Beauty Editor—My Favorite LED Face Mask Is 30% Off Before Prime Day Ends Tonight  Women's Health

I'm A Beauty Editor—My Favorite LED Face Mask Is 30% Off Before Prime Day Ends Tonight - Women's Health

Click here to get full coverage on uniQure: Further Upside Likely As The Opportunity Becomes Better Understood (QURE) - Seeking Alpha

uniQure: Further Upside Likely As The Opportunity Becomes Better Understood (QURE)  Seeking Alpha

uniQure: Further Upside Likely As The Opportunity Becomes Better Understood (QURE) - Seeking Alpha

Click here to get full coverage on Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against uniQure N.V. (QURE) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against uniQure N.V. (QURE) and Encourages Stockholders to Learn More About the Investigation  ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against uniQure N.V. (QURE) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Click here to get full coverage on uniQure (QURE) Shares Plummet Over 57% - GuruFocus

uniQure (QURE) Shares Plummet Over 57%  GuruFocus

uniQure (QURE) Shares Plummet Over 57% - GuruFocus

Click here to get full coverage on uniQure N.V. (QURE): A Bull Case Theory - Insider Monkey

uniQure N.V. (QURE): A Bull Case Theory  Insider Monkey

uniQure N.V. (QURE): A Bull Case Theory - Insider Monkey

Click here to get full coverage on uniQure N.V. (QURE) Price Target Increased by 88.86% to 69.17 - Nasdaq

uniQure N.V. (QURE) Price Target Increased by 88.86% to 69.17  Nasdaq

uniQure N.V. (QURE) Price Target Increased by 88.86% to 69.17 - Nasdaq

Click here to get full coverage on uniQure (QURE) Price Target Lowered by HC Wainwright & Co. | QUR - GuruFocus

uniQure (QURE) Price Target Lowered by HC Wainwright & Co. | QUR  GuruFocus

uniQure (QURE) Price Target Lowered by HC Wainwright & Co. | QUR - GuruFocus

Click here to get full coverage on QURE Stock To $500? - Forbes

QURE Stock To $500? - Forbes

Click here to get full coverage on Is QURE stock recession proof - Portfolio Return Report & Free Technical Confirmation Trade Alerts - newser.com

Is QURE stock recession proof - Portfolio Return Report & Free Technical Confirmation Trade Alerts  newser.com

QURE

Price Chart

Key Statistics

Technicals

About QURE

Latest News

uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences - Yahoo Finance

A Deep Dive into uniQure (QURE) Valuation After FDA Uncertainty Shakes Huntington’s Disease Program - simplywall.st

New Analyst Forecast: $QURE Given $60.0 Price Target - Quiver Quantitative

Advanced Charts

Top Gainers

Top Losers